Containment In-Vitro Packaging 
XTalks
JANUARY 29, 2024
Many companies have significantly pushed for sustainable packaging and efficient energy utilization, but medical device companies still need to catch up in sustainability approaches. Coloplast is focused on improving its products and packaging vis-à-vis reducing emissions.
Advarra
SEPTEMBER 23, 2022
Whether the drug’s proposed labeling (package insert) is appropriate, and what it should contain. . The Food and Drug Administration (FDA) is the federal entity in the U.S. charged with (among other things) “ensur[ing] that safe and effective drugs are available to improve the health of the people in the United States.” .
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pfizer
DECEMBER 13, 2022
Nirmatrelvir has shown consistent in vitro antiviral activity against the following variants: Alpha, Beta, Delta, Gamma, Lambda, Mu, and Omicron BA.1, One carton contains five blister packs of PAXLOVID, as co-packaged nirmatrelvir tablets with ritonavir tablets, providing all required doses for a full five-day treatment course.
The Pharma Data
SEPTEMBER 1, 2020
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions. Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection status. Food and Drug Administration (FDA).
The Pharma Data
JANUARY 31, 2021
They are well established drug targets, particularly in neurological and cardiovascular diseases, but many remain undrugged or poorly drugged, and may be tractable to structure-based approaches. Metrion will contribute intellectual property, know-how and use of screening models for the nominated ion channel target. ” About Sosei Heptares.
Pfizer
AUGUST 15, 2022
Nirmatrelvir has shown consistent in vitro antiviral activity against the following variants: Alpha, Beta, Delta, Gamma, Lambda, Mu, and Omicron BA.1 One carton contains five blister packs of PAXLOVID, as co-packaged nirmatrelvir tablets with ritonavir tablets, providing all required doses for a full five-day treatment course.
Pfizer
JANUARY 27, 2023
The European Commission (EC) will review the CHMP recommendation and is soon expected to make a final decision. This opinion from the CHMP confirms that the benefits of PAXLOVID in helping to reduce severe COVID-19-related outcomes, including hospitalization and death, in high risk patients continue to outweigh its potential risks.
Expert insights. Personalized for you.
64 
Let's personalize your content